Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026)

Turn Therapeutics has reported Shares Outstanding for 3 years, with the latest figure at $29.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 9.29% year-over-year to $29.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.8 million (up 9.29% YoY), and the FY2025 full-year result was $29.4 million, up 9.68% from the prior year.
• Shares Outstanding for Q1 2026 stood at $29.8 million, up from $29.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $29.8 million in Q1 2026, with the low at $26.7 million in Q3 2024.
• Average Shares Outstanding over 3 years is $28.0 million, with a median of $27.6 million recorded in 2025.
• Peak annual rise in Shares Outstanding reached 9.68% in 2025, while the deepest fall reached 4.99% in 2025.
• Tracing TTRX's Shares Outstanding over 3 years: stood at $26.8 million in 2024, then gained by 9.68% to $29.4 million in 2025, then gained by 1.16% to $29.8 million in 2026.
• The last three Shares Outstanding figures came in at $29.8 million (Q1 2026), $29.4 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.

Peer Comparison